Despite protein kinases clearly being implicated in the pathogenesis of childhood sarcomas, and kinase inhibitors showing promising activity in preclinical models, successful translation into the clinic for most sarcomas has been limited and remains an ongoing area of investigation. Here, WEE1 is linked to sarcoma.